On Monday, President Bashar al-Assad issued Legislative Decree No.14 for 2020, exempting production requirements and raw materials used in manufacturing pharmaceuticals for human use from customs.
The decree, which is valid for one year as of the date it comes into force, also exempts these materials from all other taxes and fees imposed on imports.
This article was edited by The Syrian Observer. The Syrian Observer has not verified the content of this story. Responsibility for the information and views set out in this article lies entirely with the author.
